Literature DB >> 10447714

Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling.

H Kanda1, T Mimura, K Hamasaki, K Yamamoto, Y Yazaki, H Hirai, Y Nojima.   

Abstract

We have previously shown that engagement of the T-cell receptor (TCR)/CD3 complex with anti-CD3 antibody induces tyrosine phosphorylation of p105CasL (CasL), a member of the p130Cas docking protein family. In the present work, we attempted to determine which protein tyrosine kinases (PTKs) regulate TCR-mediated phosphorylation of CasL. We show here that an association between CasL and two types of Src family PTKs, Fyn and Lck, is induced by anti-CD3 cross-linking of human H9 T cells. In contrast, ZAP-70, another PTK that also plays a critical role in the TCR signalling, failed to bind CasL, even after anti-CD3 stimulation. In vitro kinase assays revealed that Fyn and Lck, but not ZAP-70, were capable of phosphorylating CasL. Moreover, we found that CasL was constitutively hyperphosphorylated in vivo in splenocytes of MRL-MP-lpr/lpr mice, in which overproduction and excessive activation of Fyn and Lck have previously been shown to occur. Constitutive in vivo binding of CasL to both kinases was also demonstrated in lpr splenocytes. These results strongly suggest that CasL is a substrate for Fyn and Lck PTKs in TCR signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447714      PMCID: PMC2326814          DOI: 10.1046/j.1365-2567.1999.00753.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.

Authors:  R D York; H Yao; T Dillon; C L Ellig; S P Eckert; E W McCleskey; P J Stork
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

2.  Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4- CD8- T lymphocytes from lpr/lpr mice.

Authors:  T Katagiri; J P Ting; R Dy; C Prokop; P Cohen; H S Earp
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs.

Authors:  Y Nojima; N Morino; T Mimura; K Hamasaki; H Furuya; R Sakai; T Sato; K Tachibana; C Morimoto; Y Yazaki
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

4.  The abnormal lpr double-negative T cell fails to proliferate in vivo.

Authors:  E S Sobel; V N Kakkanaiah; R G Rapoport; R A Eisenberg; P L Cohen
Journal:  Clin Immunol Immunopathol       Date:  1995-02

5.  Focal adhesion kinase (pp125FAK) is tyrosine phosphorylated after engagement of alpha 4 beta 1 and alpha 5 beta 1 integrins on human T-lymphoblastic cells.

Authors:  Y Nojima; K Tachibana; T Sato; S F Schlossman; C Morimoto
Journal:  Cell Immunol       Date:  1995-03       Impact factor: 4.868

6.  Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders.

Authors:  L E Samelson; W F Davidson; H C Morse; R D Klausner
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

7.  A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.

Authors:  R Sakai; A Iwamatsu; N Hirano; S Ogawa; T Tanaka; H Mano; Y Yazaki; H Hirai
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

8.  RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts.

Authors:  S J Cook; B Rubinfeld; I Albert; F McCormick
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

9.  Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein.

Authors:  Y Nojima; D M Rothstein; K Sugita; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells.

Authors:  J E Maguire; K M Danahey; L C Burkly; G A van Seventer
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  7 in total

1.  Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.

Authors:  Arthur R Salomon; Scott B Ficarro; Laurence M Brill; Achim Brinker; Qui T Phung; Christer Ericson; Karsten Sauer; Ansgar Brock; David M Horn; Peter G Schultz; Eric C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

2.  Abl family kinases modulate T cell-mediated inflammation and chemokine-induced migration through the adaptor HEF1 and the GTPase Rap1.

Authors:  Jing Jin Gu; Catherine P Lavau; Elena Pugacheva; Erik J Soderblom; M Arthur Moseley; Ann Marie Pendergast
Journal:  Sci Signal       Date:  2012-07-17       Impact factor: 8.192

Review 3.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

Review 4.  Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.

Authors:  Mahendra Singh; Lauren Cowell; Sachiko Seo; Geraldine O'Neill; Erica Golemis
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

5.  Tyrosine kinases EnAbling adaptor molecules for chemokine-induced Rap1 activation in T cells.

Authors:  Laurent P Malherbe; Demin Wang
Journal:  Sci Signal       Date:  2012-07-31       Impact factor: 8.192

6.  Myosin IIA modulates T cell receptor transport and CasL phosphorylation during early immunological synapse formation.

Authors:  Yan Yu; Nicole C Fay; Alexander A Smoligovets; Hung-Jen Wu; Jay T Groves
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

7.  Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.

Authors:  Tim N Beck; Emmanuelle Nicolas; Meghan C Kopp; Erica A Golemis
Journal:  Oncoscience       Date:  2014-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.